Nanobody Targets HSV Glycoprotein B to Neutralize Herpes Viruses

TL;DR
Researchers developed a prefusion-specific nanobody that neutralizes HSV-1 and HSV-2 by binding to glycoprotein B, preventing its conformational change necessary for viral fusion, with detailed structural insights provided by cryo-EM.
- A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2 Nature
- Nanobody Against Herpes The National Tribune
Want the full story? Read the original reporting
Read on Nature